Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

A-PRF

PreclinicalBiologic

KKing Abdulaziz University

2

Indications

4

Total Trials

2

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Impact MolarActive, not recruiting

Impact MolarPreclinical

Active, not recruiting

Timeline

Expected Milestones

Q2 2027

PreclinicalActive, not recruiting

Impact Molar

NCT07652216

Clinical

Trials by Indication[1]

Surgical1 trial

Pinhole Surgical Technique for Root Coverage Using PRF

Unknown status·KKrishnadevaraya College of Dental Sciences & Hospital·Phase 2·NCT04202198·20 enrolled

Hemostasis1 trial

Comparison of A-PRF vs Bone Wax in Hemostasis, Pain Relief and Healing Following Exodontia

Unknown status·—·N/A·NCT05744726·129 enrolled

Complication1 trial

Platelet-Derived Growth Factors to Enhance Healing and Reduce Post-Extraction Complications in Smokers

Not yet recruiting·KKing Abdulaziz University·N/A·NCT07364890·12 enrolled

Impact Molar1 trial

Bone Defects Reconstruction After Dentigerous Cyst Enucleation With Autogenous Demineralized Dentin Matrix- ADDM and Advanced Platelet-Rich Fibrin- A-PRF.

Active, not recruiting·JJagiellonian University·Preclinical·NCT07652216·35 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for A-PRF. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — A-PRF compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for A-PRF. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — King Abdulaziz University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: KKing Abdulaziz University

Related News